Live Breaking News & Updates on That Prolong

Stay updated with breaking news from That prolong. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BioXcel Therapeutics Announces FDA Approval of IGALMI™ (dexmedetomidine) Sublingual Film for Acute Treatment of Agitation Associated with Schizophrenia or Bipolar I or II Disorder in Adults

First and only FDA-approved orally dissolving sublingual film for mild, moderate or severe agitation in patients with schizophrenia or bipolar I or II disorder1 IGALMI demonstrated onset of. | April 6, 2022 ....

United States , Helen Ogorman , Matt Ventimiglia , John Krystal , Erik Kopp , Vimal Mehta , Robertl Mcneil Jr , Yale School Of Medicine , Bioxcel Therapeutics Inc , Drug Administration , National Comorbidity Survey Replication , Department Of Psychiatry , Journal Of The American Medical Association , National Institute Of Mental Health , While The Company , Translational Research , Globenewswire Inc , Xcel Therapeutics , Negative Syndrome Scale Excited Component , American Medical Association , Agitation Associated , Bipolar Disorder , Orthostatic Hypotension , Withdrawal Reactions , That Prolong , Geriatric Patients ,